dc.contributor.author | Belmonte, N | fr_FR |
dc.contributor.author | Vernochet, C | fr_FR |
dc.contributor.author | Dani, C | fr_FR |
dc.date.accessioned | 2012-08-30T12:32:16Z | |
dc.date.available | 2012-08-30T12:32:16Z | |
dc.date.issued | 2000 | fr_FR |
dc.identifier.citation | Belmonte, N ; Vernochet, C ; Dani, C, Invalidation génique de PPARγ : malgré la létalité, des révélations suprenantes., Med Sci (Paris), 2000, Vol. 16, N° 2; p.253-4 | fr_FR |
dc.identifier.issn | 1958-5381 | fr_FR |
dc.identifier.uri | http://hdl.handle.net/10608/1630 | |
dc.language.iso | fr | fr_FR |
dc.publisher | Masson, Paris | fr_FR |
dc.rights | Article en libre accès | fr |
dc.rights | Médecine/Sciences - Inserm - SRMS | fr |
dc.source | M/S. Médecine sciences [revue papier, ISSN : 0767-0974], 2000, Vol. 16, N° 2; p.253-4 | fr_FR |
dc.title | Invalidation génique de PPARγ : malgré la létalité, des révélations suprenantes. | fr |
dc.title.alternative | PPAR γ is required for placental, cardiac, and adipose tissue development. | fr_FR |
dc.type | Article | fr_FR |
dc.contributor.affiliation | Centre de biochimie, UMR 6543 Cnrs, Parc Valrose, 06180 | - |
dc.identifier.doi | 10.4267/10608/1630 | |